Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Neuralgia 2Neoplasms 2Chronic Pain 2Wounds and Injuries 1Peripheral Nervous System Diseases 1Pain, Intractable 1Lymphoma, Follicular 1HIV Infections 1Bronchiolitis Obliterans Syndrome 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Fentanyl 27Analgesia 23Morphine 20Acupuncture Therapy 18Surveys and Questionnaires 16Oxycodone 16Zoledronic Acid 15Acetaminophen 14Therapeutics 13Radiotherapy 13Psychiatric Rehabilitation 13Ketamine 13Methadone 11Lidocaine 11Hydromorphone 11Bupivacaine 11nabiximols 10Ibandronic Acid 10Ropivacaine 9Early Intervention, Educational 7Analgesics, Opioid 7Saline Solution 6Music Therapy 6Cryotherapy 6Cryosurgery 6Yoga 5Water 5Tapentadol 5Pregabalin 5Methods 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pain × ziconotide × Clear all
NCT00996983 2023-03-24

ZIDON

National Cancer Institute, Naples

Phase 2 Unknown
16 enrolled

Neoplasms, Neuralgia, Pain, Pain, Intractable

NCT00002160 2005-06-24

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
100 enrolled

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Neoplasms, Pain, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡